Brain Imaging Study of F17464

Phase 1

Completed

• Conditions: Healthy Volunteers
• Interventions: Drug: F17464

• Registration Number: NCT01689038
• Lead Sponsor: Pierre Fabre Medicament

Brief Summary

Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-09-14
• Study First Submitted QC: 2012-09-14
• Study First Posted: 2012-09-20
• Study Start: 2012-11
• Status Verified: 2013-02
• Primary Completion: 2013-02
• Study Completion: 2013-02
• Last Update Submitted: 2013-02-13
• Last Update Posted: 2013-02-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 8

Inclusion Criteria

• Male healthy volunteers

Exclusion Criteria

• Presence or positive history of severe medical illness or psychiatric conditions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Tested product	F17464	-

Primary Outcome Measures

Name	Time	Method
Binding rate to cerebral receptors	up to 29 hours	by brain imaging